Word Count : 241

---

Hybridoma technology is a technique used to produce monoclonal antibodies by fusing a specific type of immune cell (B-cell) with a cancerous cell (myeloma cell). The result of this fusion is a hybrid cell known as a hybridoma, which combines the characteristics of both parent cells. The B-cell provides the ability to produce a specific antibody, while the myeloma cell ________ ___ ________ _______ ______ _______.
___ _________ ______ _____ ___ _______.
_____ ________ ____ ___ _____ ________.
___ _____ ________ _____ _______ ________ _________ _____ _________ __________ ______ _______.
______ ___ ________ ____ _______ __________.
_______ _____ _____ ____ ________ ___ ______ ________ _______.
_______ _______ _______ __________ ________ _______ _____ _________ __________ ___ ___.
______ _______ ___ _________ _______ ______ ________ __________ ________ _________.
____ __________ ___ ______ _______ ________ ______ ___ ______ __________ _________.
_________ ______ _____ ___ _________ _____ ________ ______ _______ __________ __________ ___.
______ _____ ________ _______ ______ _______ ____ ____.
_______ ________ _______ ________ _________ ____ ___ ________ _______ _______.
________ _________ _________ ________ ______ ______ ______ ________ __________.
__________ _________ _________ __________ ____ _____ ____ ___ _____ ___ _________.
__________ ________ _______ ________ ________ _______ ____ _________ _____ _____ ________.
_____ _______ __________ ___ ________ _____ ______ ____ ______ ________ __________ ________.
__________ ___ ____ ________ ___.
_________ _________ _________ _______ ___ ___ _________.
_______ __________ ________ _________ ______ __________.
_________ _____ _____ ____ ____ ______ ____ _____ ________ ___.
_______ _______ ____.
Get Full Answer on WhatsApp